A/Pr Trent Woodruff
NHMRC
Australia
Therapeutic targeting of neuroinflammation to slow the progression of neurodegenerative disease
NHMRC
314,996
01/01/16
5.0
Motor neurone diseases
neuroinflammation | complement activation | therapeutic target | motor neuron disease (mnd) | parkinson disease
My research has identified key components of our immune system, that can worsen disease in conditions such as Parkinsons disease and motor neuron disease. I hope that exploring these components in animal models, and patients suffering from these diseases, my group can identify new therapeutic drug candidates that can be progressed in clinical trials. Ultimately, this may lead to new treatments to reduce disease burden in patients suffering from these neurodegenerative conditions.